Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Novarel administration during fertility treatments impact progesterone levels in the luteal phase, and what are its implications for endometrial receptivity and implantation success?
1. Novarel increases LH levels, boosting progesterone during the luteal phase, enhancing endometrial receptivity and implantation chances.
2. By triggering LH surges, Novarel raises progesterone, vital for preparing a receptive endometrium, thus improving implantation success rates.
1. Novarel, an hCG-based drug, increases progesterone in the luteal phase, enhancing endometrial receptivity and potentially improving implantation rates.
2. By mimicking LH surge, Novarel boosts progesterone production, critical for preparing the endometrium for embryo implantation, thus increasing the likelihood of pregnancy.
3. Administering Novarel in fertility treatments spikes progesterone levels during the luteal phase, fostering a more favorable environment for embryo implantation and enhancing success rates.